LXRX - Lexicon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LXRX is currently covered by 2 analysts with an average price target of $4.55. This is a potential upside of $2.56 (144.62%) from yesterday's end of day stock price of $1.86.

Lexicon Pharmaceuticals's activity chart (see below) currently has 41 price targets and 61 ratings on display. The stock rating distribution of LXRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.85% with an average time for these price targets to be met of 48.23 days.

Highest price target for LXRX is $6, Lowest price target is $3.1, average price target is $4.55.

Most recent stock forecast was given by from CITI on 11-May-2026. First documented stock forecast 01-Jul-2015.

Currently out of the existing stock ratings of LXRX, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Jan-2021

$3.1

$0.55 (21.57%)

$2.3

4 months 13 days ago
(11-May-2026)

4/13 (30.77%)

$0.79 (34.20%)

85

Buy Since 16-Jul-2024

$6

$3.45 (135.29%)

$6

6 months 1 days ago
(23-Mar-2026)

0/15 (0%)

$4.36 (265.85%)

Hold Since 07-Mar-2023

$0.85

$-1.7 (-66.67%)

$3

1 years 1 months 18 days ago
(06-Aug-2025)

1/2 (50%)

$-0.3 (-26.09%)

58

Buy Since 12-Aug-2022

$10

1 years 6 months 17 days ago
(07-Mar-2025)

0/8 (0%)

$7.99 (397.51%)

Buy Since 09-Nov-2015

$8

$6.28 (365.12%)

5 years 7 months 26 days ago
(29-Jan-2021)

2/7 (28.57%)

$0.09 (1.14%)

206

Show more analysts

Please expand the browser size to see the chart

What is LXRX (Lexicon Pharmaceuticals) average time for price targets to be met?

On average it took 48 days for the stock forecasts to be reached, with an average price target met ratio of 33.85%.

Which analyst most recently updated their price target on LXRX (Lexicon Pharmaceuticals)?

Which analyst has the most public recommendations on LXRX (Lexicon Pharmaceuticals)?

has 0 price targets and 0 ratings on LXRX

Which analyst is the currently most bullish on LXRX (Lexicon Pharmaceuticals)?

Liana Moussatos with the highest potential upside of $6.28

Which analyst is the currently most reserved on LXRX (Lexicon Pharmaceuticals)?

Andrew Tsai with the lowest potential downside of -$1.7
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?